Low expression of ryanodine receptor 2 is associated with poor prognosis in thyroid carcinoma
N Xu, D Zhang, J Chen, G He… - Oncology Letters, 2019 - spandidos-publications.com
Genetic alterations are vital in the progression of thyroid carcinoma. Ryanodine receptor 2
(RyR2) is reported to serve an important role in several types of human carcinoma …
(RyR2) is reported to serve an important role in several types of human carcinoma …
Identification of hub lncRNAs along with lncRNA-miRNA-mRNA network for effective diagnosis and prognosis of papillary thyroid cancer
H Li, F Liu, X Wang, M Li, Z Li, Y Xie… - Frontiers in …, 2021 - frontiersin.org
Long noncoding RNAs (lncRNAs) play important roles in tumorigenesis and progression of
different cancers and they have been potential biomarkers for cancer diagnosis and …
different cancers and they have been potential biomarkers for cancer diagnosis and …
ID1 and ID4 are biomarkers of tumor aggressiveness and poor outcome in immunophenotypes of breast cancer
M Garcia-Escolano, YG Montoyo-Pujol… - Cancers, 2021 - mdpi.com
Simple Summary Inhibitor of differentiation (ID) proteins are essential to promote
proliferation during embryonic development, but they are silenced in most adult tissues …
proliferation during embryonic development, but they are silenced in most adult tissues …
Inhibitor of DNA-binding protein 4 suppresses cancer metastasis through the regulation of epithelial mesenchymal transition in lung adenocarcinoma
CC Wang, YL Hsu, CJ Chang, CJ Wang, TH Hsiao… - Cancers, 2019 - mdpi.com
Metastasis is a predominant cause of cancer death and the major challenge in treating lung
adenocarcinoma (LADC). Therefore, exploring new metastasis-related genes and their …
adenocarcinoma (LADC). Therefore, exploring new metastasis-related genes and their …
Loss of ID3 drives papillary thyroid cancer metastasis by targeting E47-mediated epithelial to mesenchymal transition
S Xu, C Mo, J Lin, Y Yan, X Liu, K Wu, H Zhang… - Cell Death …, 2021 - nature.com
Papillary thyroid cancer (PTC) is the main histological type of thyroid cancer and accounts
for almost all increased cases worldwide. Patients with PTC exhibit a favorable prognosis …
for almost all increased cases worldwide. Patients with PTC exhibit a favorable prognosis …
Estudio piloto para la determinación de la expresión de ID1, ID3 e IGJ en Leucemia Linfoblástica Aguda B a partir de muestras de médula ósea
OC Lozano Camelo - repositorio.unal.edu.co
La Leucemia Linfoblástica Aguda B (LLA-B), es una malignidad que se desarrolla en la
médula ósea, comprometiendo los precursores hematopoyéticos de linaje B. La población …
médula ósea, comprometiendo los precursores hematopoyéticos de linaje B. La población …
Inhibitor of DNA-binding family regulates the prognosis of ovarian cancer
Q Zhou, YD Mei, HJ Yang, YL Tao - Future Oncology, 2021 - Taylor & Francis
Aim: The mechanistic role of inhibitor of DNA binding or differentiation (ID) family in ovarian
cancer (OC) has remained unclear. Materials & methods: We used the Oncomine, GEPIA …
cancer (OC) has remained unclear. Materials & methods: We used the Oncomine, GEPIA …
ID1 and ID4 Are Biomarkers of Tumor Aggressiveness and Poor Outcome in Immunophenotypes of Breast Cancer. Cancers 2021, 13, 492
M Garcia-Escolano, YG Montoyo-Pujol… - 2021 - search.proquest.com
Inhibitor of differentiation (ID) proteins are a family of transcription factors that contribute to
maintaining proliferation during embryogenesis as they avoid cell differentiation. Afterward …
maintaining proliferation during embryogenesis as they avoid cell differentiation. Afterward …